Association for Molecular Pathology v. Myriad Genetics


Oyez Project

In June 2013, the Supreme Court held that naturally occurring gene sequences and their naturally occurring derivatives are not patent eligible.  This link includes a brief summary of the case, as well as the full opinion and links to the audio of oral argument.

Read More

Myriad Gene Patent Litigation

Genomics Law Report

This link provides several viewpoints regarding the Myriad Genetics case.

Read More

7 Takeaways from Supreme Court’s Gene Patent Decision

Daily News, National Geographic

Shortly after the Supreme Court ruling in Myriad, this article summarizes the implications of the decision and its influence on the biotech industry.

Read More

Gene Patents

The Hastings Center Bioethics Briefing Book
Robert Cook-Deegan

Intended for a lay audience, this chapter outlines key issues in the debate about gene patents and summarizes historical developments in the field.

Read More

Patents in Genomics and Human Genetics

Annual Review of Genomics and Human Genetics
Robert Cook-Deegan and Christopher Heaney

This article provides a more detailed and scholarly overview of the issues.

Read More

Debunking the Myth that Whole-Genome Sequencing Infringes Thousands of Gene Patents

Nature Biotechnology
Christopher M. Holman

This article addresses misconceptions regarding gene patents and whole-genome sequencing.

Read More

Mayo Collaborative Services v. Prometheus Laboratories


Oyez Project

In this case, the Supreme Court held that the processes involved in a test for proper dosages of drug treatments are unpatentable laws of nature.

Read More

Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine


Congressional Research Service

This article discusses the implications of the Mayo v. Prometheus decision, including its potential impact on gene patents.  It also suggests possible routes that Congress can take on the issue of gene patenting.

Read More